搜尋
Climb Bio Inc
CLYM添加自選
12.100USD
+0.200+1.68%
收盤 07-31 16:00（美東）報價延遲15分鐘
825.03M總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
其他
60.64%
持股股東
持股股東
佔比
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
其他
60.64%
股東類型
持股股東
佔比
Venture Capital
28.89%
Hedge Fund
14.53%
Investment Advisor
10.51%
Investment Advisor/Hedge Fund
7.74%
Research Firm
1.03%
Individual Investor
0.39%
Pension Fund
0.15%
其他
36.77%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
194
35.98M
59.67%
-6.59M
2025Q4
180
50.12M
94.21%
+7.08K
2025Q3
182
50.11M
95.00%
-5.30M
2025Q2
174
55.41M
95.70%
-2.05M
2025Q1
161
57.46M
90.60%
-8.97M
2024Q4
149
56.10M
86.82%
+979.54K
2024Q3
120
56.83M
81.50%
+4.66M
2024Q2
84
51.93M
31.41%
+31.40M
2024Q1
82
18.86M
80.37%
-3.42M
2023Q4
86
18.86M
80.98%
+125.11K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
RA Capital Management, LP
11.30M
23.66%
+7.11K
+0.06%
Jan 05, 2026
Pontifax Venture Capital
5.21M
10.9%
--
--
Mar 31, 2025
MPM BioImpact LLC
2.67M
5.59%
+2.67M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.92M
4.03%
+1.40M
+265.07%
Dec 31, 2025
Adar1 Capital Management LLC
1.43M
3%
+1.30M
+972.77%
Dec 31, 2025
Affinity Asset Advisors LLC
1.30M
2.72%
--
--
Dec 31, 2025
Kynam Capital Management LP
1.03M
2.15%
--
--
Dec 31, 2025
Great Point Partners, LLC
979.53K
2.05%
+979.53K
--
Dec 31, 2025
Sphera Funds Management Ltd.
932.25K
1.95%
+497.41K
+114.39%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ProShares Ultra Nasdaq Biotechnology
0.01%
iShares Biotechnology ETF
0.01%
Invesco Nasdaq Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Neuroscience and Healthcare ETF
0%
iShares Russell 2000 Value ETF
0%
查看更多
ProShares Ultra Nasdaq Biotechnology
佔比0.01%
iShares Biotechnology ETF
佔比0.01%
Invesco Nasdaq Biotechnology ETF
佔比0.01%
iShares Micro-Cap ETF
佔比0.01%
Avantis US Small Cap Equity ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Neuroscience and Healthcare ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%